New FDA-Approved Cellular Therapy for Metastatic Melanoma Now Available at Baylor University Medical Center in Dallas
After
more than 18 months of working to meet the criteria to become an authorized treatment center, Baylor University Medical Center is poised to be one of the first in the nation to offer a newly FDA-approved tumor-infiltrating lymphocytes (TIL) cellular therapy
treatment for patients with metastatic melanoma.